Literature DB >> 29808630

A reflection on the challenges in interviewing Arab participants.

Rasmieh Mustafa Al-Amer1, Lucie Ramjan2, Paul Glew3, Tamara Taysir Darwish4, Sue Randall5, Yenna Salamonson2.   

Abstract

BACKGROUND: Cultural beliefs and ways of thinking need to be considered when interviewing Arab participants with chronic diseases. AIM: To provide insights into the challenges of interviewing Arab participants. DISCUSSION: This paper taps into the first author's experiences of interviewing ten Arab participants with type 2 diabetes and coexisting depression. Issues relating to gatekeeping, gender, participants' privacy and superstitious thinking need to be taken into consideration, particularly when discussing sensitive topics that may challenge social norms. These issues can influence the building of rapport, which may affect the depth of information collected.
CONCLUSION: This paper offers insight and recommendations for other researchers conducting qualitative research with Arab participants. IMPLICATIONS FOR PRACTICE: Paramount in conducting qualitative studies with Arab participants are: an early, open discussion about personal space with participants and their families; matching the genders of participants and interviewers; and involving participants in the selection of pseudonyms. ©2018 RCN Publishing Company Ltd. All rights reserved. Not to be copied, transmitted or recorded in any way, in whole or part, without prior permission of the publishers.

Entities:  

Keywords:  culture; depression; diabetes; ethnicity; qualitative research; reflection; research

Mesh:

Year:  2018        PMID: 29808630     DOI: 10.7748/nr.2018.e1559

Source DB:  PubMed          Journal:  Nurse Res        ISSN: 1351-5578


  1 in total

1.  Exploring the Representation of Depressive Symptoms and the Influence of Stigma in Arabic-Speaking Refugee Outpatients.

Authors:  Nico Lindheimer; Carine Karnouk; Eric Hahn; Dana Churbaji; Laura Schilz; Diana Rayes; Malek Bajbouj; Kerem Böge
Journal:  Front Psychiatry       Date:  2020-11-12       Impact factor: 4.157

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.